DE68903425D1 - Verbindungen mit zentraler analgetischer verwendung, verfahren zu ihrer herstellung und arzneimittel die sie enthalten. - Google Patents

Verbindungen mit zentraler analgetischer verwendung, verfahren zu ihrer herstellung und arzneimittel die sie enthalten.

Info

Publication number
DE68903425D1
DE68903425D1 DE8989108788T DE68903425T DE68903425D1 DE 68903425 D1 DE68903425 D1 DE 68903425D1 DE 8989108788 T DE8989108788 T DE 8989108788T DE 68903425 T DE68903425 T DE 68903425T DE 68903425 D1 DE68903425 D1 DE 68903425D1
Authority
DE
Germany
Prior art keywords
analgetic
compounds
central
production
products containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8989108788T
Other languages
English (en)
Other versions
DE68903425T2 (de
Inventor
Angelo Carenzi
Dario Chiarino
Bella Davide Della
Gian Carlo Grancini
Carlo Veneziani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zambon SpA
Original Assignee
Zambon SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT20648/88A external-priority patent/IT1217657B/it
Priority claimed from IT8919480A external-priority patent/IT1230754B/it
Application filed by Zambon SpA filed Critical Zambon SpA
Application granted granted Critical
Publication of DE68903425D1 publication Critical patent/DE68903425D1/de
Publication of DE68903425T2 publication Critical patent/DE68903425T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74—Oxygen atoms
    • C07D211/76—Oxygen atoms attached in position 2 or 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE8989108788T 1988-05-20 1989-05-16 Verbindungen mit zentraler analgetischer verwendung, verfahren zu ihrer herstellung und arzneimittel die sie enthalten. Expired - Fee Related DE68903425T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT20648/88A IT1217657B (it) 1988-05-20 1988-05-20 Composti con attivita' analgesica centrale
IT8919480A IT1230754B (it) 1989-02-17 1989-02-17 Camposti con attivita' analgesica centrale.

Publications (2)

Publication Number Publication Date
DE68903425D1 true DE68903425D1 (de) 1992-12-17
DE68903425T2 DE68903425T2 (de) 1993-03-25

Family

ID=26327181

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8989108788T Expired - Fee Related DE68903425T2 (de) 1988-05-20 1989-05-16 Verbindungen mit zentraler analgetischer verwendung, verfahren zu ihrer herstellung und arzneimittel die sie enthalten.

Country Status (15)

Country Link
US (1) US4960788A (de)
EP (1) EP0342613B1 (de)
JP (1) JP2802437B2 (de)
AU (1) AU624382B2 (de)
CA (1) CA1336333C (de)
DE (1) DE68903425T2 (de)
DK (1) DK172008B1 (de)
ES (1) ES2043943T3 (de)
FI (1) FI90662C (de)
GR (1) GR3006803T3 (de)
HU (1) HU208420B (de)
IE (1) IE61631B1 (de)
IL (1) IL90324A0 (de)
NO (1) NO174463C (de)
SU (1) SU1727531A3 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2653123B1 (fr) * 1989-10-17 1992-01-17 Roussel Uclaf Nouveaux derives de la pyridone, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
IT1239950B (it) * 1990-03-28 1993-11-27 Zambon Spa Processo per la preparazione di composti con attivita' analgesica centrale
US5208345A (en) * 1990-12-17 1993-05-04 Merrell Dow Pharmaceuticals Inc. Process for the production of (S)-vinyl and allenyl gaba
AU644919B2 (en) * 1990-12-17 1993-12-23 Aventisub Ii Inc. Process for the production of (S)-vinyl and allenyl gaba
US7105537B2 (en) 2003-01-28 2006-09-12 Bristol-Myers Squibb Company 2-substituted cyclic amines as calcium sensing receptor modulators
US7205322B2 (en) 2003-02-12 2007-04-17 Bristol-Myers Squibb Company Thiazolidine compounds as calcium sensing receptor modulators
US7265145B2 (en) 2003-05-28 2007-09-04 Bristol-Myers Squibb Company Substituted piperidines and pyrrolidines as calcium sensing receptor modulators and method
CA2632453A1 (en) * 2005-12-07 2007-06-14 Ucb Pharma, S.A. 3-carboxy- 2-oxo-1 -pyrrolidine derivatives and their uses
CN115475162B (zh) * 2022-10-18 2023-06-02 浙江震元制药有限公司 4-异丁基-2-吡咯烷酮在制备镇痛药物中的应用、一种镇痛药物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2496163A (en) * 1948-03-30 1950-01-31 Du Pont Synthesis of a 2-substituted-5-oxopyrrolidine
BE790747A (fr) * 1971-10-30 1973-02-15 Whitefin Holding Sa Stereo-isomeres du 1-(1'-(0-chloro-benzyl)-pyrrol-2'-yl) -2-dibutyl sec.-amino-ethanol et procede pour leur preparation
IE45511B1 (en) * 1976-09-01 1982-09-08 Ciba Geigy Ag New derivatives of perhydro-aza-heterocycles and processesfor the production thereof
US4525476A (en) * 1983-05-26 1985-06-25 Warner-Lambert Company N-[1-oxo-3-(5-oxo-2-pyrrolidinyl)propyl]-alpha-aminoacids and derivatives as cognition activators
FR2549053B1 (fr) * 1983-07-12 1985-12-27 Sanofi Sa Nouveaux derives de la pyrrolidine actifs sur le systeme nerveux central, leur procede de preparation, les medicaments en contenant
DE3336024A1 (de) * 1983-10-04 1985-04-18 Boehringer Ingelheim KG, 6507 Ingelheim 4-amino-l-benzyl-pyrrolidinone und ihre saeureadditionssalze, verfahren zu ihrer herstellung und arzneimittel
DE3420193A1 (de) * 1984-05-30 1985-12-05 Boehringer Ingelheim KG, 6507 Ingelheim Neue substituierte pyrrolidinone, verfahren zu ihrer herstellung und arzneimittel

Also Published As

Publication number Publication date
IE891578L (en) 1989-11-20
DE68903425T2 (de) 1993-03-25
HU208420B (en) 1993-10-28
JP2802437B2 (ja) 1998-09-24
FI90662B (fi) 1993-11-30
AU624382B2 (en) 1992-06-11
CA1336333C (en) 1995-07-18
FI892420A0 (fi) 1989-05-19
NO174463C (no) 1994-05-11
GR3006803T3 (de) 1993-06-30
DK172008B1 (da) 1997-09-15
NO892021L (no) 1989-11-21
HUT50765A (en) 1990-03-28
DK244389A (da) 1989-12-20
NO174463B (no) 1994-01-31
EP0342613A1 (de) 1989-11-23
SU1727531A3 (ru) 1992-04-15
IL90324A0 (en) 1989-12-15
AU3499389A (en) 1989-11-23
NO892021D0 (no) 1989-05-19
FI90662C (fi) 1994-03-10
DK244389D0 (da) 1989-05-19
JPH0217176A (ja) 1990-01-22
US4960788A (en) 1990-10-02
IE61631B1 (en) 1994-11-16
EP0342613B1 (de) 1992-11-11
ES2043943T3 (es) 1994-01-01
FI892420A (fi) 1989-11-21

Similar Documents

Publication Publication Date Title
DE3671627D1 (de) Tertiaere hydroxyalkylxanthine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung.
DE58904567D1 (de) Quinuclidine, ihre verwendung als arzneimittel und verfahren zu ihrer herstellung.
DE68904104D1 (de) Phenol-substituierte gem-diphosphonat-derivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel.
DE3860503D1 (de) 10-dihydro-10-deoxo-11-azaerythronolid-a-verbindungen,verfahren und zwischenprodukte zu ihrer herstellung und ihre verwendung in arzneimitteln und in deren herstellung.
ATA312987A (de) Brenzkatechin-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneistoffe
DE3575724D1 (de) Quinolizinon-verbindungen, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
DE68904364D1 (de) (aza)naphtalensultam-derivate, verfahren zu deren herstellung und arzneimittel, die sie enthalten.
DE68908374D1 (de) Propenonoximether, verfahren zu dessen herstellung sowie diese enthaltende arzneinmittel.
ATE32459T1 (de) Substituierte phenylsulfonyloxybenzimidazolcarbaminate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
DE68905585T2 (de) 2-imino-benzothiazolin-derivate, verfahren zu deren herstellung und arzneimittel, die sie enthalten.
DE3579000D1 (de) Imidazolylalkylguanidinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
DE68901039D1 (de) Indolylpiperidin-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische verbindungen.
DE3577199D1 (de) Semicarbazidderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
DE68903425D1 (de) Verbindungen mit zentraler analgetischer verwendung, verfahren zu ihrer herstellung und arzneimittel die sie enthalten.
DE68903484T2 (de) 2-imino-6-polyfluoralkoxy-benzothiazol-derivate, verfahren zu deren herstellung und arzneimittel, die sie enthalten.
DE68912944D1 (de) Phenylpyrole, verwendbar als arzneimittel, verfahren zu ihrer herstellung und ihre verwendung.
DE3484023D1 (de) Azolylmethylcycloalkane, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
DE3883164D1 (de) Rhodanin-derivate, verfahren zu ihrer herstellung, ihre anwendung und pharmazeutische zusammensetzungen, die sie enthalten.
ATE6250T1 (de) Substituierte phenoxy-aminopropanol-derivate, zwischenprodukte und verfahren zu ihrer herstellung sowie diese enthaltende arzneimittel.
ATE9795T1 (de) Benzoyl-phenyl-piperidin-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
DE3678707D1 (de) A-aminoaryldihydropyridinlactone, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln.
ATE82260T1 (de) Verbindungen mit zentraler analgetischer verwendung, verfahren zu ihrer herstellung und arzneimittel die sie enthalten.
DE3677609D1 (de) 3-piperidinyl- 1h-indazole, verfahren zu deren herstellung und deren anwendung als arzneimittel.
DE3881566T2 (de) Antitumor-derivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten.
ATE87310T1 (de) 2-imino-benzothiazolin-derivate, verfahren zu deren herstellung und arzneimittel, die sie enthalten.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee